Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms

OBJECTIVE: Neurological symptoms (NS) were often reported in COVID-19 infection. We examined the plasma levels of glial fibrillary acidic protein (GFAP) and S100B together, as brain injury biomarkers, in relation to persistent NS in a cohort of patients with COVID-19 during the acute phase of the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahin, B.E., Celikbilek, A., Kocak, Y., Saltoglu, G.T., Konar, N.M., Hizmali, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212259/
https://www.ncbi.nlm.nih.gov/pubmed/35752131
http://dx.doi.org/10.1016/j.jns.2022.120324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212259/
https://www.ncbi.nlm.nih.gov/pubmed/35752131
http://dx.doi.org/10.1016/j.jns.2022.120324

Ejemplares similares